Načítá se...
Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?
Recent studies indicate that cancer antigen 125 (CA125) response criteria tend to overestimate a tumour reduction measured by standard WHO response criteria in recurrent epithelial ovarian carcinoma. The aim of the study was to validate the recently introduced GCIG (The Gynaecological Cancer Intergr...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2409573/ https://ncbi.nlm.nih.gov/pubmed/14735180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601501 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|